Oncology Researchers Awarded DHT Summer Studentships
News Jul 01, 2013
The DHT scheme, now in its second year, enables undergraduates to extend their studies over the summer period by gaining practical lab experience, using non-animal approaches, that will further our understanding of devastating diseases.
Each award is worth up to £1,440 over a maximum 8 week period, with a separate budget of up to £500 available for consumables.
Professor Blair’s student, Jonathan Carr, who is studying for a BSc in Medical Biochemistry, will extend his studies by gaining practical laboratory experience to understand whether human adenoviruses can enter, spread and migrate through a multi-cellular tumour spheroid and whether this process can be monitored in real time using live cell imaging techniques.
Professor Hanemann’s student, Jade Lyons-Rimmer, who is studying for a BSc in Clinical Sciences, will aim to identify novel binding partners of KSR1 in human Schwann cells using a proteomics-based approach to further understand the roles of KSR1 in proliferation and apoptosis of Schwann cells. This project offers exciting replacement potential and this non-animal approach alone will prevent approximately 190 mice being used.
Kailah Eglington, Chief Executive of the Dr Hadwen Trust, said: “Our Summer Studentship award is an opportunity to inspire the next generation of research students.
“We are really encouraged by the quality and quantity of the entries we have received this year. The winners of our awards clearly demonstrated how their animal-alternative research techniques had the potential to replace the use of many animals in conventional biomedical research.
"We are confident that the projects chosen will deliver not only valuable science but whet an appetite in these students to continue this work long after they graduate."
Shedding Light on How Tumors Become Resistant to ImmunotherapyNews
Researchers have now found that in skin cutaneous melanoma an epigenetic control protein is key to the development of immunotherapy resistance.READ MORE
Ingestible Drug-Delivery Materials May Improve Patient Treatment ComplianceNews
Hydrogel-based capsules could expand and reside in the GI tract for days, slowly releasing medication.READ MORE
Nanoparticle Delivery of Curcumin Induces Tumor Cell DeathNews
Attaching curcumin, a component of the common spice turmeric, to nanoparticles can be used to target and destroy treatment-resistant neuroblastoma tumor cellsREAD MORE
Comments | 0 ADD COMMENT
International Conference and Exhibition on Nanomedicine and Nanotechnology
Nov 23 - Nov 24, 2017
11th Edition of International Conference on Proteomics 2018
Mar 22 - Mar 23, 2018